spot_img

      Subscribe Now!

 

Saturday, May 21, 2022
spot_img
spot_img

Lankenau Medical Center Symposium to Feature the Latest Advances in Cardiac Arrhythmia Care

Hellenic News
Hellenic Newshttps://www.hellenicnews.com
The copyrights for these articles are owned by HNA. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of HNA and its representatives.

Latest articles

 

(Wynnewood, Pa, March 29, 2016) – Health care professionals who treat patients with cardiac arrhythmias are invited to attend an upcoming symposium to be held at Lankenau Medical Center (LMC), part of Main Line Health, on Saturday, May 21, 2016.

 

“Cardiac Arrhythmias: Emerging Concepts and Novel Approaches to Therapy” will feature lectures by several renowned experts in arrhythmia syndromes, ventricular tachycardia, device implantation, atrial fibrillation and anticoagulation drug therapy. Attendees will learn about the latest scientific discoveries and treatment options. Lecturers will include physicians and researchers from LMC, Lankenau Institute for Medical Research (LIMR), Lankenau Heart Institute, and the Perelman School of Medicine at the University of Pennsylvania.

 

Thanks for reading Hellenic News of America

“We look forward to gathering together some of the top regional experts in arrhythmias for a day devoted to improving patients’ health, longevity and well-being,” said Peter Kowey, MD, William Wikoff Smith Chair, Cardiovascular Research at Lankenau Institute for Medical Research and Professor of Medicine and Clinical Pharmacology at Sidney Kimmel Medical College of Thomas Jefferson University. “So many new and novel approaches in cardiac arrhythmia care have emerged in recent years that it may be difficult for health care professionals to keep track of the very latest developments. Symposium participants will be able to return to their practices armed with the most up-to-date, evidence-based, practical information to improve patient outcomes.”

 

Charles Antzelevitch, Ph.D., Professor and Executive Director of Cardiovascular Research at LIMR, and Director of Research at Lankenau Heart Institute, noted, “The meeting is also designed to provide an understanding of genetic, cellular and molecular mechanisms underlying the development of cardiac arrhythmias, as well as the mechanisms underlying the ameliorative effects of drugs and other therapeutic modalities.”

 

The symposium is open to electrophysiologists, cardiologists and allied health care professionals, including nurse practitioners, physicians’ assistants and technicians, who treat patients with cardiac arrhythmias. Registration is required. Physician continuing education credits will be available. The full agenda for this one-day educational event is available here.

 

The event will be held in the auditorium at LMC, 100 Lancaster Ave., Wynnewood, Pa., from 8 a.m. to 4:30 pm. For more information and to register, visit https://events.medtelligence.net/lan16.html or click here.

 

About Lankenau Medical Center

Lankenau Medical Center, a member of Main Line Health, is recognized as a national leader in advancing new options to diagnose and treat illness, protect against disease and save lives. Located on a 93-acre campus just outside of Philadelphia, Lankenau Medical Center is a 389-bed, not-for-profit teaching hospital that includes one of the nation’s leading cardiovascular centers; the Lankenau Institute for Medical Research, one of the few freestanding hospital-associated research centers in the nation; and the Annenberg Conference Center for Medical Education, that trains over 100 new physicians each year through nationally ranked residency and fellowship programs. Lankenau has received both regional and national recognition for its excellence in providing state-of-the-art, quality care. Lankenau is ranked as number six in Pennsylvania and number four in the Philadelphia metro area in US News & World Report’s Best Hospitals. LMC is also ranked nationally for diabetes and endocrinology, and is high-performing in eight specialties: cardiology and heart surgery, diabetes and endocrinology, gastroenterology and GI surgery, geriatrics, neurology and neurosurgery, orthopedics, pulmonology and urology. Lankenau has achieved The Joint Commission’s Gold Seal of Approval for stroke care and breast cancer care and is one of the nation’s Top Performing Hospitals for heart attack, heart failure, pneumonia and surgical care. Lankenau has also been ranked for multiple years as one of the top 50 cardiovascular hospitals in the nation by Truven Health Analytics. Lankenau has also earned the highest distinction for excellence in nursing care, the American Nurses Credentialing Center Magnet® designation. For more information about Lankenau Medical Center, visit mainlinehealth.org/lankenau.

 

About Lankenau Institute for Medical Research

Founded in 1927, the Lankenau Institute for Medical Research (LIMR) is an independent, nonprofit biomedical research center located in suburban Philadelphia on the campus of Lankenau Medical Center. Part of Main Line Health, LIMR is one of the few freestanding, hospital-associated medical research centers in the nation. The faculty and staff at the Institute are dedicated to advancing an understanding of the causes of cancer, heart disease, diabetes and other illnesses. This information is used to help improve diagnosis and treatment of these diseases, as well as find ways to prevent them. LIMR is also committed to extending the boundaries of human health and well-being through technology development and the training of the next generation of scientists and physicians. To learn about LIMR, visit limr.org.

The copyrights for these articles are owned by the Hellenic News of America. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of the Hellenic News of America and its representatives.

Get Access Now!

spot_img
spot_img